Alimera Sciences, Inc. (NASDAQ: ALIM) Starts Presentation at LD Micro Main Event
Alimera Sciences (NASDAQ: ALIM) is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in our aging populations. Alimera’s commitment to retina specialists and their patients is manifest in Alimera’s product and development portfolio designed to treat early- and late-stage diseases. For more information, visit the company’s website at www.alimerasciences.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news…







